The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 09, 2021

Filed:

Dec. 20, 2018
Applicant:

Bioverativ Therapeutics Inc., Waltham, MA (US);

Inventors:

Joe Salas, Wayland, MA (US);

Elena Kistanova, Brookline, MA (US);

Vu Phong Hong, Cambridge, MA (US);

Adam R. Mezo, Carmel, IN (US);

Robert T. Peters, Needham, MA (US);

Assignee:

Bioverativ Therapeutics, Inc., Waltham, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/64 (2006.01); A61K 47/62 (2017.01); A61K 38/36 (2006.01); A61K 38/48 (2006.01);
U.S. Cl.
CPC ...
C12N 9/6432 (2013.01); A61K 38/36 (2013.01); A61K 38/4846 (2013.01); A61K 47/62 (2017.08); C12N 9/6437 (2013.01); C12Y 304/21006 (2013.01); C12Y 304/21021 (2013.01);
Abstract

The invention provides chimeric clotting factors comprising an activatable clotting factor and an enhancer moiety. The activatable clotting factor allows the chimeric clotting factor to be activated at the site of coagulation. The enhancer moiety can additionally improve procoagulation activities of the chimeric clotting factors. The chimeric clotting factors can further be improved by fusion to a half-life extender, which improves a pharmacokinetics property of the chimeric clotting factor. The invention also includes methods of making and methods of using these chimeric clotting factors.


Find Patent Forward Citations

Loading…